PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
204.73%
Net income growth above 1.5x TSM's 15.81%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-6.28%
Negative yoy D&A while TSM is 126.10%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-65.88%
Both reduce yoy usage, with TSM at -171.69%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-25.29%
Negative yoy inventory while TSM is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-1041.04%
Negative yoy usage while TSM is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-100.47%
Negative yoy while TSM is 230.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
36.23%
Operating cash flow growth similar to TSM's 38.31%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-139.00%
Negative yoy CapEx while TSM is 100.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-81.86%
Negative yoy purchasing while TSM stands at 71.97%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-288.14%
Both yoy lines negative, with TSM at -2582.70%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-444.87%
Both yoy lines negative, with TSM at -5.03%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-77.35%
Negative yoy issuance while TSM is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.